Syntho Chirals Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 12 Year, 3 Months
- Last Filing with ROC 31 Mar 2021
- Revenue Growth %
- Profit Growth -494.38%
- Ebitda -577.38%
- Net Worth -37.03%
- Total Assets -20.82%
About Syntho Chirals Lifesciences
Syntho Chirals Lifesciences Private Limited (SCLPL) is a Private Limited Indian Non-Government Company incorporated in India on 15 November 2012 and has a history of 12 years and three months. Its registered office is in Rangareddy, Telangana, India.
The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Sridhar Ragi, Linga Ragi, Sunanda Arrvapalli, and Two other members serve as directors at the Company.
Company Details
- Location
Rangareddy, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24100TG2012PTC084162
- Company No.
084162
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
15 Nov 2012
- Date of AGM
30 Nov 2021
- Date of Balance Sheet
31 Mar 2021
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Syntho Chirals Lifesciences?
Board Members (5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sridhar Ragi  | Director | 10-May-2013 | Current |
| Linga Ragi | Director | 15-Nov-2012 | Current |
| Sunanda Arrvapalli | Director | 15-Nov-2012 | Current |
| Saidulu Akrapu | Director | 03-Feb-2020 | Current |
| Sujatha Mirdoddi | Director | 03-Feb-2020 | Current |
Financial Performance of Syntho Chirals Lifesciences.
Syntho Chirals Lifesciences Private Limited, for the financial year ended 2018, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 494.38% decrease in profit. The company's net worth observed a substantial decline by a decrease of 37.03%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Syntho Chirals Lifesciences?
In 2018, Syntho Chirals Lifesciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Syntho Chirals Private LimitedSridhar Ragi and Linga Ragi are mutual person
Vaidhatru Pharma Private LimitedLinga Ragi is a mutual person
- Bioartis Life Sciences Private Limited
Sunanda Arrvapalli is a mutual person
- Leafgen Biotech Private Limited
Sunanda Arrvapalli is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Syntho Chirals Lifesciences?
Unlock and access historical data on people associated with Syntho Chirals Lifesciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Syntho Chirals Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Syntho Chirals Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.